If You Invested in Oxford Immunotec (OXFD)
Looking for the current price? See the OXFD quote & overviewWhat $1,000 or $10,000 in OXFD Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Nov 2, 2015 |
|---|---|---|---|---|
| $1,000 | — | — | $1,710 +71% | $1,734 +73% |
| $10,000 | — | — | $17,100 +71% | $17,342 +73% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2021-03-05. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for OXFD$1,000 Investment Over Time
OXFD vs S&P 500Year-by-Year Returns
OXFD annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015 | $12.68 | $11.50 | -9.3% | -9.3% |
| 2016 | $11.50 | $14.95 | +30.0% | +17.9% |
| 2017 | $14.95 | $13.97 | -6.6% | +10.2% |
| 2018 | $13.97 | $12.78 | -8.5% | +0.8% |
| 2019 | $12.78 | $16.60 | +29.9% | +30.9% |
| 2020 | $16.60 | $17.46 | +5.2% | +37.7% |
| 2021 | $17.46 | $21.99 | +25.9% | +73.4% |
About Oxford Immunotec
NASDAQ
Frequently Asked Questions
Oxford Immunotec investment returns
How much would $1,000 invested in Oxford Immunotec be worth today?
If you invested $1,000 in Oxford Immunotec (OXFD) 10 years ago on 2016-10-31, your investment would be worth $1,710 as of 2021-03-05, a +71.0% price return without dividends, growing at a compounded rate of 13.2% per year (CAGR).
Has Oxford Immunotec outperformed the S&P 500?
Over the past 10 years, OXFD returned +71.0% compared to +262.0% for the S&P 500, underperforming the benchmark by 191.0 percentage points.
What is Oxford Immunotec's average annual return?
The compound annual growth rate (CAGR) of OXFD’s share price over the past 10 years is 13.2%, without dividends. Individual years vary a great deal, and OXFD’s best recent full year was 2016 (+30.0%) while the worst was 2018 (-8.5%).
For informational and educational purposes only, not investment advice.